Diag Capital Management »

Abbott Laboratories shares owned by Diag Capital Management

Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by Diag Capital Management from 13F filings

Historical chart of Diag Capital Management investment in Abbott Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Abbott Laboratories held by Diag Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbott Laboratories by Diag Capital Management

Quarter filed Position value Share count Share price at filing
2018-12-31 $2.8M 39k 72.33

More positions owned by Diag Capital Management

Baxter International (BAX)
Athenex
Zimmer Holdings (ZBH)
Abbvie (ABBV)
Incyte Corporation (INCY)
Quanterix Ord (QTRX)
Celgene Corporation
Amgen (AMGN)
Foamix Pharmaceuticals
Medtronic (MDT)
Quotient
Pacira Pharmaceuticals conv
Takeda Pharmaceutical (TAK)
Abbott Laboratories (ABT)
Zai Lab (ZLAB)

View all positions for Diag Capital Management

Top funds holding Abbott Laboratories

Vanguard Group
BlackRock
State Street Corporation
Capital Research and Management Company - Division 3
Capital Research Global Investors
Geode Capital Management
Morgan Stanley
Jpmorgan Chase & Co
Wellington Management Company
Northern Trust
T. Rowe Price Investment Management
Wells Fargo & Company
Goldman Sachs Group
Massachusetts Financial Services
Invesco

View all funds holding Abbott Laboratories